Filing Flows › Precision Biosciences (DTIL) › Q2 FY26 › vs Q1 FY26
Precision Biosciences (DTIL) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Precision Biosciences's revenue rose $34.2M (2,631×) from $13K in Q1 FY26 to $34.2M in Q2 FY26.
Precision Biosciences, Q2 FY26: revenue $34.2M (54× year over year), operating margin 36.6%, net earnings $20.1M, operating cash flow −$11.2M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $34.2M | $13K | $34.2M | 2,631× |
| Other income, net | $7.6M | −$1.1M | $8.7M | — |
| Operating profit | $12.5M | −$20.7M | $33.2M | — |
| Costs & expenses | $21.7M | $20.7M | $1.0M | +5% |
| Pre-tax earnings | $20.1M | −$21.8M | $41.9M | — |
| Research & development | $14.5M | $13.4M | $1.1M | +8% |
| General & admin | $7.2M | $7.3M | −$96K | -1% |
| Net earnings | $20.1M | −$21.8M | $41.9M | — |
| Operating cash sources | $33.8M | −$3.8M | $37.5M | — |
| Depreciation & amortization | $345K | $350K | −$5K | -1% |
| Share-based compensation | $2.0M | $2.4M | −$345K | -14% |
| Cash used in operations | $11.2M | $15.3M | −$4.0M | -26% |
| Working capital & other | $33.8M | −$3.8M | $37.5M | — |
Questions
How much did Precision Biosciences's revenue grow quarter over quarter in Q2 FY26?
Precision Biosciences's revenue rose $34.2M (2,631×) from $13K in Q1 FY26 to $34.2M in Q2 FY26.